U.S. restrictions on foreign-manufactured mobile robots may mark the formal start of U.S.-China decoupling in humanoid robots

Overview

This report assesses the potential policy tools, escalation paths, and supply-chain implications for U.S.-China competition in humanoid robots following U.S. restrictions on new foreign-manufactured mobile robots. Its core view is that the U.S. may continue to lead the escalation of restrictions, while China may respond through data and rare-earth resource policies.

Core views

Potential subsequent U.S. measures include entity-list designations, the Foreign Direct Product Rule, and investment restrictions targeting leading Chinese companies. China has advantages in high-value robot-training data accumulation and domestic-market scale, but its robotics industry remains dependent on U.S. AI chips and simulation platforms. If restrictions escalate, the market will promote localization of Chinese AI chips and simulation platforms and accelerate global supply-chain restructuring.

Analysis framework

By comparing the evolution of U.S.-China policies in the automotive, telecommunications, and drone industries, the report maps both sides' policy toolkits and assesses the impact on four categories of participants: U.S. system manufacturers, non-Chinese component suppliers, Chinese system manufacturers, and Chinese component suppliers.

Methodology notes

• Policy scenario analysisPolicy toolkit and escalation scenarios

  Maps baseline and escalation scenarios to tools including market access, export controls, investment restrictions, data controls, and rare-earth controls.

  Used to identify the relative impact of different policy measures on various supply-chain participants.

• Supply-chain analysisRobot value-chain mapping

  Covers systems, components, AI chips, simulation platforms, and rare-earth permanent magnet materials.

  Used to assess demand protection, supply-chain substitution, and localization opportunities created by decoupling.

Asset mapping & comparison

Structured mapping from thesis to named assets (strengths, weaknesses, peers, risks).

• U.S. domestic humanoid robot system manufacturers (Tesla, Figure, Agility)

  Direct potential beneficiaries of U.S. market-access restrictions

  Strengths

  Greater protection in the domestic market, with competitive foreign supply constrained.

  Weaknesses

  They must still address challenges in technology maturity, mass production, and costs.

  Comparison

  They benefit more from U.S. market barriers than Chinese system manufacturers.

  Risks

  Uncertainty remains regarding policy scope, enforcement intensity, and demand realization.

• Chinese humanoid robot system manufacturers

  Non-U.S. market expansion opportunities coexist with technology-restriction risks

  Strengths

  China has a large market and is accumulating high-value training data rapidly.

  Weaknesses

  Reliance on U.S. AI chips and simulation platforms.

  Comparison

  Access to the U.S. market is constrained, but they can draw on Hikvision's experience of continued expansion in overseas markets.

  Risks

  Export controls, entity-list designations, and coordinated restrictions by allied countries may expand.

• Chinese component suppliers (Shuanghuan Driveline, Tuopu Group, Hesai Technology, Orbbec)

  Companies with overseas production capacity may benefit from growth in both supply chains

  Strengths

  They can serve China's robotics industry and may enter U.S. supply chains.

  Weaknesses

  Cross-border supply-chain and compliance requirements are increasing.

  Comparison

  Companies with overseas operations are more resilient than suppliers serving only a single market.

  Risks

  Trade restrictions, customer supply-chain restructuring, and disruptions in rare-earth materials.

• Non-Chinese component suppliers (Schaeffler, Harmonic Drive)

  Potential beneficiaries of U.S. customer supply-chain diversification

  Strengths

  They can capture substitute procurement demand from U.S. customers.

  Weaknesses

  Capacity expansion and cost competitiveness may be constrained.

  Comparison

  They are better aligned than Chinese suppliers with U.S. customers' need to reduce China exposure.

  Risks

  Chinese countermeasures and global demand volatility.

• Robot AI chips and simulation platforms (Horizon Robotics, Black Sesame)

  Potential beneficiaries of Chinese technology localization

  Strengths

  They can extend autonomous-driving chip experience into robotics.

  Weaknesses

  They still lag the U.S. full-stack hardware and software ecosystem.

  Comparison

  The more pronounced the escalation of restrictions, the stronger the demand for local substitution.

  Risks

  Technology deployment, commercialization progress, and valuation risks.

Key data

• Galbot high-quality data expansion target10x increase within two yearsThe report views the scarcity of training data as a key bottleneck for humanoid robots.
• Horizon Robotics target price10 HKDRating: Outperform.
• Black Sesame target price16 HKDRating: Underperform.
• Hesai Technology HSAI.US target priceUSD 30.00Rating: Outperform.
• Tuopu Group 601689.CH target priceCNY 75.00Rating: Outperform.

Impact & implications

U.S. market barriers may protect domestic humanoid robot system manufacturers such as Tesla, Figure, and Agility. Leading Chinese system manufacturers can still expand in non-U.S. markets; Chinese component suppliers with overseas production capacity may serve both Chinese and U.S. supply chains. To diversify supply risk, U.S. customers may increase purchases from non-Chinese suppliers such as Schaeffler and Harmonic Drive. If technology restrictions extend to chips and simulation, they will accelerate Chinese localization.

Risks

• U.S. restrictions may expand to entity-list designations, the Foreign Direct Product Rule, investment restrictions, or coordinated measures with allied countries.
• Chinese countermeasures on data or rare-earth permanent magnet materials may intensify supply-chain uncertainty.
• China's robotics industry's reliance on U.S. AI chips and simulation platforms may constrain near-term development.
• Uncertainty remains around policy implementation timing, coverage, and treatment of existing products.
• Humanoid robot commercialization, mass-production schedules, and end demand may fall short of expectations.

What to watch

• The specific scope of U.S. FCC restrictions and whether they will apply retroactively to existing models.
• Whether the U.S. will place Chinese robotics companies on the Entity List, under investment restrictions, or on other sanctions lists.
• Whether China will introduce rules governing cross-border transfer and use of full-lifecycle robot data.
• Whether China will tighten exports of rare-earth permanent magnet materials and related long-arm jurisdiction measures.
• Progress in localization of Chinese AI chips, simulation platforms, and robot-training data.
• Overseas capacity expansion by Chinese component suppliers and their adoption by U.S. customers.